Contraindications. This is a general description of the disease or condition and the patient population for which the device should not be used for the purpose of diagnosing, treating, curing or mitigating. Contraindications are conditions under which the device should not be used because the risk of use clearly outweighs any possible benefit.
Contraindications. Advanced arteriosclerosis; agitated states; hyperthyroidism; moderate hypertension; severe hypertension; symptomatic cardiovascular disease Adverse effects Common or Very Common Abdominal cramps, aggression, agitation, anxiety, constipation, decreased appetite, depression, diarrhea, dizziness, dry mouth, dyspnoea, growth restriction, headache, irritability, labile mood, nausea, palpitations, pyrexia, rash, restlessness, sleep disturbances, somnolence, tachycardia, tics, vomiting and weight loss Uncommon Agitation, bruxism, cardiomyopathy, chest pain, dermatillomania, dysgeusia, dyskinesia, dysphoria, euphoria, hallucinations, hypertension, logorrhea, mania, mydriasis, psychomotor hyperactivity, Raynaud’s Syndrome, sexual dysfunction, sweating, urticarial, visual disturbances Frequency not known Psychotic episodes and seizures. Drug interactions - Refer to current Summary of Product Characteristics (SPC): xxx.xxxxxxxxx.xxx.xx Lisdexamfetamine Shared Care Agreement I have read the Lisdexamfetamine Shared Care Agreement Please circle a response A) I am willing to prescribe Lisdexamfetamine and adhere to the terms in this Shared Care Agreement B) I am not willing to prescribe Lisdexamfetamine as per this Shared Care Agreement Name (Print)
Contraindications. General contraindications for coronary stenting and for the use of this device are: · Unprotected left main coronary artery disease; · Coronary artery spasm; · Lesions involving a bifurcation; · Cardiogenic shock; · Any patients judged to have a lesion which may prevent proper stent deployment; · Vessel trauma requiring surgical repair or reintervention · Total occlusion of target lesion · Ejection fraction <30%; · Allergies to required procedural medications; · Lesions involving arterial segments with highly tortuous anatomy; · Severe reaction to contrast agents; · Contraindication for anti-platelets and/or anti-coagulation therapy; · Known allergies to Stainless Steel or Polyethelyne Theraphalate. · Cardiac Tamponade · Emboli, distal (air, tissue or thrombotic emboli) · Emergent Coronary Artery Bypass Surgery (CABG) · Pericardial effusion · Pseudoaneurysm, femoral · Respiratory Failure · Shock/Pulmonary edema
Contraindications. Budenofalk® 2mg rectal foam must not be used in: - hypersensitivity to budesonide or any of the ingredients - hepatic cirrhosis with signs of portal hypertension, e.g. late-stage primary biliary cirrhosis
Contraindications. Advanced arteriosclerosis; agitated states; hyperthyroidism; moderate hypertension; severe hypertension; symptomatic cardiovascular disease Cautions Bipolar disorder; history of cardiovascular disease; history of substance abuse; may lower seizure threshold (discontinue if seizures occur); psychotic disorders; susceptibility to angle-closure glaucoma; tics; Tourette syndrome. Adverse effects Common or very common Abdominal cramps, aggression, agitation, anxiety, constipation, decreased appetite, depression, diarrhea, dizziness, dry mouth, dyspnoea, growth restriction, headache, irritability, labile mood, nausea, palpitations, pyrexia, rash, restlessness, sleep disturbances, somnolence, tachycardia, tics, vomiting and weight loss Uncommon Agitation, bruxism, cardiomyopathy, chest pain, dermatillomania, dysgeusia, dyskinesia, dysphoria, euphoria, hallucinations, hypertension, logorrhea, mania, mydriasis, psychomotor hyperactivity, Raynaud’s Syndrome, sexual dysfunction, sweating, urticarial, visual disturbances Frequency not known Psychotic episodes and seizures. For other adverse effects refer to current Summary of Product Characteristics (SPC): xxx.xxxxxxxxx.xxx.xx or British National Formulary for Children (BNFC), available at xxx.xxx.xxx, Drug interactions Refer to current Summary of Product Characteristics (SPC): xxx.xxxxxxxxx.xxx.xx or British National Formulary for Children (BNFC), available at xxx.xxx.xxx,
Contraindications. Do not use Whole Body Cryotherapy if you have any of the following conditions: • Uncontrolled high blood pressure • Cold Allergy • Prior heart attack • Open sores • Unstable chest pain • Nerve pain in feet or legs • Disease of blood vessels • Pregnancy • History of blood clots You may have other conditions that make whole body cryotherapy inappropriate. Consult with your physician or medical advisor if you have questions as to whether whole body cryotherapy is right for you.
Contraindications. “In all paediatric patients (0-18 years of age) who undergo tonsillectomy and/or adenoidectomy for obstructive sleep apnoea syndrome due to an increased risk of developing serious and life-threatening adverse reactions (see section 4.4)” “In women during breastfeeding (see section 4.6)” “In patients for whom it is known they are CYP2D6 ultra-rapid metabolisers”
